Search research articles
Contact Us
Filters
Showing results (1-10 of 89) with videos related to
Page
of 9
Sort By:
Atherosclerosis
|
June 20, 2016
Hypoglycemia and the predisposition to cardiovascular disease: Is the pro-inflammatory-pro-coagulant diathesis a plausible explanation?
Ishwarlal Jialal, Sandeep Dhindsa
Current Diabetes Reports
|
January 7, 2014
Potential anti-atherosclerotic effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus
Sandeep Dhindsa, Ishwarlal Jialal
Metabolic Syndrome and Related Disorders
|
June 29, 2012
Bariatric surgery for the metabolic syndrome: magic bullet or not?
Sandeep Dhindsa, Ishwarlal Jialal
The Journal of Clinical Endocrinology and Metabolism
|
September 8, 2011
Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity
Paresh Dandona, Sandeep Dhindsa
Metabolic Syndrome and Related Disorders
|
February 14, 2014
No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus: potential explanations
Ishwarlal Jialal, Sandeep Dhindsa
The Journal of Clinical Endocrinology and Metabolism
|
June 5, 2025
Letter to the Editor From Mauvais-Jarvis and Dhindsa: "Approach to the Patient: Low Testosterone Concentrations in Men With Obesity"
Franck Mauvais-Jarvis, Sandeep Dhindsa
The Journal of Family Practice
|
May 4, 2007
Testosterone deficiency: which patients should you screen and treat?
Richard Sadovsky, Sandeep Dhindsa, Katherine Margo
Diabetes
|
May 23, 2015
Comment on Heni et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 2014;63:4083-4088
Sandeep Dhindsa, Gurkiran Dhindsa, Rama Chemitiganti
Diabetes
|
February 26, 2015
Nonesterified fatty acids, albumin, and platelet aggregation
Sandeep Dhindsa, Husam Ghanim, Paresh Dandona
Androgens: Clinical Research and Therapeutics
|
January 16, 2023
Hypogonadotropic Hypogonadism in Diabesity: Pathogenic Factors and Therapeutic Implications
Paresh Dandona, Sandeep Dhindsa, Husam Ghanim
Page
of 9
Search research articles
Search
Showing results (1-10 of 89) with videos related to
Sort By:
Page
of 9
Atherosclerosis
|
June 20, 2016
Hypoglycemia and the predisposition to cardiovascular disease: Is the pro-inflammatory-pro-coagulant diathesis a plausible explanation?
Ishwarlal Jialal, Sandeep Dhindsa
Current Diabetes Reports
|
January 7, 2014
Potential anti-atherosclerotic effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus
Sandeep Dhindsa, Ishwarlal Jialal
Metabolic Syndrome and Related Disorders
|
June 29, 2012
Bariatric surgery for the metabolic syndrome: magic bullet or not?
Sandeep Dhindsa, Ishwarlal Jialal
The Journal of Clinical Endocrinology and Metabolism
|
September 8, 2011
Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity
Paresh Dandona, Sandeep Dhindsa
Metabolic Syndrome and Related Disorders
|
February 14, 2014
No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus: potential explanations
Ishwarlal Jialal, Sandeep Dhindsa
The Journal of Clinical Endocrinology and Metabolism
|
June 5, 2025
Letter to the Editor From Mauvais-Jarvis and Dhindsa: "Approach to the Patient: Low Testosterone Concentrations in Men With Obesity"
Franck Mauvais-Jarvis, Sandeep Dhindsa
The Journal of Family Practice
|
May 4, 2007
Testosterone deficiency: which patients should you screen and treat?
Richard Sadovsky, Sandeep Dhindsa, Katherine Margo
Diabetes
|
May 23, 2015
Comment on Heni et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 2014;63:4083-4088
Sandeep Dhindsa, Gurkiran Dhindsa, Rama Chemitiganti
Diabetes
|
February 26, 2015
Nonesterified fatty acids, albumin, and platelet aggregation
Sandeep Dhindsa, Husam Ghanim, Paresh Dandona
Androgens: Clinical Research and Therapeutics
|
January 16, 2023
Hypogonadotropic Hypogonadism in Diabesity: Pathogenic Factors and Therapeutic Implications
Paresh Dandona, Sandeep Dhindsa, Husam Ghanim
Page
of 9